JOURNAL TOOLS |
Publishing options |
eTOC |
To subscribe |
Submit an article |
Recommend to your librarian |
ARTICLE TOOLS |
Publication history |
Reprints |
Permissions |
Cite this article as |
Share |
YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
CASE REPORT Free access
Minerva Respiratory Medicine 2021 March;60(1):16-9
DOI: 10.23736/S2784-8477.20.01889-1
Copyright © 2020 EDIZIONI MINERVA MEDICA
language: English
Hemothorax: a rare presentation of COVID-19
Soheil EBRAHIMPOUR 1, Zeinab MOHSENI AFSHAR 2, Mahmoud SADEGHI-HADDAD-ZAVAREH 1, Masomeh BAYANI 1, Arefeh BABAZADEH 1 ✉
1 Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran; 2 Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
On December 31, 2019 novel Coronavirus (SARS-CoV-2) is the strain of Coronavirus that causes Coronavirus disease 2019 (COVID-19). It was initially reported from Wuhan, China. This novel virus causes atypical clinical presentations that differs from other viral pneumonias; in fact, some clinical aspects of infection are not cleared today. We present the case of a 69-year-old man with a 2-week history of dyspnea and hemoptysis. He was diagnosed with COVID-19 infection, confirmed by real-time reverse-transcriptase-polymerase chain reaction. On day 11 postadmission, the case’s condition improved significantly, with his oxygen saturation rising and lymphopenia subsiding. His dyspnea gradually decreased in severity; furthermore, hemoptysis was controlled after treatment. This case indicates the complexity and variety of pneumonia complications caused by COVID-19 infection. We must have a high clinical suspicion in management of suspected cases especially in patients with novel clinical presentations such as our case in a pandemic. Thus, hemothorax due to viral lung parenchymal destruction can be a complication of COVID-19 pneumonia.
KEY WORDS: COVID-19; Pneumonia; Hemothorax